{"id":43191,"date":"2020-03-11T12:06:30","date_gmt":"2020-03-11T10:06:30","guid":{"rendered":"https:\/\/newserver.fyb.de\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/"},"modified":"2020-03-11T12:06:30","modified_gmt":"2020-03-11T10:06:30","slug":"eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/","title":{"rendered":"EUR 8 million Series\u2011A for Neracare with MIG funds and&nbsp;BayBG"},"content":{"rendered":"<p>Munich \u2014 Start-up <strong>Nera\u00adCare<\/strong> GmbH, a specia\u00adlist in skin cancer risk assess\u00adment, has secu\u00adred EUR 8 million in a Series A finan\u00adcing round.  <strong>MIG Funds 10, 14 and 16<\/strong>, <strong>BayBG<\/strong> Baye\u00adri\u00adsche Betei\u00adli\u00adgungs\u00adge\u00adsell\u00adschaft and <strong>Synvie<\/strong> GmbH parti\u00adci\u00adpa\u00adted in the finan\u00adcing round. LUTZ | ABEL as legal advi\u00adsor to the inves\u00adtors MIG-Fonds and BayBG Baye\u00adri\u00adsche Betei\u00adli\u00adgungs\u00adge\u00adsell\u00adschaft has the lead in this Series\u2011A finan\u00adcing&nbsp;round.<\/p>\n<p>The round was led by <strong>MIG Fonds 10, 14 and 16<\/strong> \u2014 other inves\u00adtors include <strong>BayBG<\/strong> Baye\u00adri\u00adsche Betei\u00adli\u00adgungs\u00adge\u00adsell\u00adschaft and <strong>Synvie<\/strong> GmbH. Nera\u00adCare is active in the field of precis\u00adion medi\u00adcine against black skin cancer, defen\u00adding its unique posi\u00adtion. The start-up deve\u00adlops and markets gene expres\u00adsion tests to deter\u00admine the risk of recur\u00adrence in mali\u00adgnant mela\u00adn\u00adoma. With the help of such a mela\u00adn\u00adoma diagno\u00adsis, doctors will be able to make a relia\u00adble progno\u00adsis in the future and make infor\u00admed treat\u00adment decis\u00adi\u00adons: Pati\u00adents with low-risk tumors will thus be spared unneces\u00adsary drug thera\u00adpies, while those pati\u00adents with incon\u00adspi\u00adcuous but higher-risk tumors and ther\u00ade\u00adfore more in need of treat\u00adment can be identified.<\/p>\n<p><strong>LUTZ | ABEL provi\u00added compre\u00adhen\u00adsive advice on the finan\u00adcing round<\/strong>.<br>\nDr. Bern\u00adhard Noreisch (VC\/M&amp;A, Munich) was the lead part\u00adner. The teams also included: Jan-Phil\u00adlip Kunz (VC\/M&amp;A, Munich), Dr. Sebas\u00adtian Sumal\u00advico (VC\/M&amp;A, Munich), Cars\u00adten Huch-Hall\u00adwachs (IP, Munich) and Andreas K\u00f6ssel (Labor Law, Munich). Nera\u00adCare GmbH was advi\u00adsed by Honert (Sven Frit\u00adsche, Kai-Clemens Wehlage), the foun\u00adders were advi\u00adsed by CMS (Dr. Tilman Weichert) and the manage\u00adment by Diss\u00admann Orth (Dr. Martin Lohse). The inves\u00adtor Synvie GmbH was advi\u00adsed by Pinsent Masons (Chris\u00adtian&nbsp;Lang).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Start-up Nera\u00adCare GmbH, a specia\u00adlist in skin cancer risk assess\u00adment, secu\u00adres EUR 8 million in a Series A finan\u00adcing&nbsp;round.<\/p>\n","protected":false},"author":2,"featured_media":43202,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1373],"tags":[],"class_list":["post-43191","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-venture-capital-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>EUR 8 million Series-A for Neracare with MIG funds and BayBG - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EUR 8 million Series-A for Neracare with MIG funds and BayBG - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Start-up NeraCare GmbH, a specialist in skin cancer risk assessment, secures EUR 8 million in a Series A financing round.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-11T10:06:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/03\/mig.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1300\" \/>\n\t<meta property=\"og:image:height\" content=\"815\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"EUR 8 million Series\u2011A for Neracare with MIG funds and&nbsp;BayBG\",\"datePublished\":\"2020-03-11T10:06:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/\"},\"wordCount\":263,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/03\/mig.png\",\"articleSection\":[\"General\",\"Featured\",\"News\",\"Venture Capital\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/\",\"url\":\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/\",\"name\":\"EUR 8 million Series-A for Neracare with MIG funds and BayBG - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/03\/mig.png\",\"datePublished\":\"2020-03-11T10:06:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/03\/mig.png\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/03\/mig.png\",\"width\":1300,\"height\":815},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EUR 8 million Series\u2011A for Neracare with MIG funds and&nbsp;BayBG\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EUR 8 million Series-A for Neracare with MIG funds and BayBG - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/","og_locale":"en_US","og_type":"article","og_title":"EUR 8 million Series-A for Neracare with MIG funds and BayBG - FYB Financial Yearbook","og_description":"Start-up NeraCare GmbH, a specialist in skin cancer risk assessment, secures EUR 8 million in a Series A financing round.","og_url":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2020-03-11T10:06:30+00:00","og_image":[{"width":1300,"height":815,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/03\/mig.png","type":"image\/png"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"EUR 8 million Series\u2011A for Neracare with MIG funds and&nbsp;BayBG","datePublished":"2020-03-11T10:06:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/"},"wordCount":263,"commentCount":0,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/03\/mig.png","articleSection":["General","Featured","News","Venture Capital"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/","url":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/","name":"EUR 8 million Series-A for Neracare with MIG funds and BayBG - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/03\/mig.png","datePublished":"2020-03-11T10:06:30+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/03\/mig.png","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/03\/mig.png","width":1300,"height":815},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/eur-8-million-series-a-for-neracare-with-mig-funds-and-baybg\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"EUR 8 million Series\u2011A for Neracare with MIG funds and&nbsp;BayBG"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/43191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=43191"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/43191\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/43202"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=43191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=43191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=43191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}